Search

Search results

Dr. Thomas Werner Elected To Accera, Inc.'s Board Of Directors

... With Accera's recent US product launch of Axona(TM) for Alzheimer's disease, Dr. Werner's experience in the commercialization of ...

Article - Anna Ohlden - Mar 24 2009 - 10:02am - 0 attachments

Cognitive Ability Peaks At 22 And Declines After - Maybe

... become better at predicting the onset of dementias such as Alzheimer's disease." Salthouse's team also is surveying participants' ...

Article - News Staff - Mar 20 2009 - 12:15am - 0 attachments

Further 100 Million Euros Allocated To Netherlands-Based RD Targeting The Early Diagnosis And Treatment Of Disease

... radically improve patient outcomes for diseases such as Alzheimer's, rheumatoid arthritis, sepsis, cardiovascular disorders and the ...

Article - Anna Ohlden - Mar 10 2009 - 12:00pm - 0 attachments

ProteoTech To Present At 9th International Conference For Alzheimer's And Parkinson's Disease - Prague, Czech Republic, March 11-15, 2009

... will present at the 9th International Conference for Alzheimer's and Parkinson's Diseases, to be held in Prague, Czech Republic, ... Exebryl-1(R) for the treatment of mild-to-moderate Alzheimer's disease. Dr. Snow's talk is entitled: Exebryl-1(R): A Novel Small ...

Article - Anna Ohlden - Mar 9 2009 - 4:01pm - 0 attachments

Curcumin - Does This Indian 'Holy Powder' Ingredient Improve Cell Resistance To Infection?

... protein believed to be involved in type 2 diabetes, Alzheimer's disease, Parkinson's disease, and many other maladies. In addition, ...

Article - News Staff - Mar 6 2009 - 11:30pm - 0 attachments

Intellect Neurosciences, Inc. Announces Independent Studies On Copper Binding Properties Of Its Lead Candidate OXIGON(TM)

... 3 /PRNewswire/ -- - Studies Support Potential for Alzheimer's Disease and Other Neurodegenerative Diseases Intellect ... on development of disease-modifying therapeutic agents for Alzheimer's disease (AD), announced today that the chemical structure of ...

Article - Anna Ohlden - Mar 3 2009 - 6:00am - 0 attachments

Video: Accera Launches Axona(TM), First Medical Food Therapy To Help Manage Mild-to-Moderate Alzheimer's Disease

... today launched Axona(TM) in the United States for Alzheimer's disease (AD). Axona is a first-in-class medical food for the ... the metabolic processes associated with mild-to-moderate Alzheimer's. Dispensed by prescription, it targets the metabolic deficiencies ...

Article - Anna Ohlden - Mar 2 2009 - 9:01am - 0 attachments

Dr. William Sears And Ocean Nutrition Take Flight On American Airlines To Spread Consumer Awareness Of The Health Benefits Of Omega-3 EPA/DHA

... symptoms of attention deficit and hyperactivity disorder, Alzheimer's, depression, postpartum depression, and stress. There is also ...

Article - Anna Ohlden - Mar 2 2009 - 8:00am - 0 attachments

Mrs. Lily Safra To Make Charitable Donations On Three Continents: Two UK Institutions To Receive Support

... Research) - EUR 7,000,000: Claude Pompidou Institute for Alzheimer's Disease, Nice - EUR 8,000,000: Institute for Brain and Spinal Cord ...

Article - Anna Ohlden - Mar 2 2009 - 5:00am - 0 attachments

Old Cells Work Differently Than Young Ones

... of age-related neurodegenerative illnesses such as Alzheimer's disease. Cellular survival thus depends on a controlled removal of ... neurodegenerative illnesses in humans, such as Alzheimer's disease and Parkinson's disease. Effective protein quality control ...

Article - News Staff - Feb 28 2009 - 12:12pm - 0 attachments